India generic drugmakers’ woes put new focus on quality over price

[Reuters] – A spate of regulatory warnings for India’s generic drug manufacturers will add a new emphasis on the quality of such medicines in an industry long dominated by the ability to deliver treatments as cheaply as possible, analysts say. In the sho more

View todays social media effects on CVS

View the latest stocks trending across Twitter. Click to view dashboard

See who CVS is hiring next, click here to view